search
Back to results

Informational App Development for mHealth for Patient Self-Management of Opioid Use Disorder (KIOS-I)

Primary Purpose

Opioid-Related Disorders

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
KIOS Informational App
Sponsored by
Biomedical Development Corporation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Opioid-Related Disorders

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Male or female outpatients 18 years of age or older Currently enrolled in an opioid treatment program and receiving medication assisted treatment for opioid use disorder Currently stable in opioid use disorder outpatient treatment for 4 weeks or longer Ability to access the app via smart phone, or tablet. Exclusion Criteria: Unwilling or unable to comply with study requirements Have a psychiatric or medical disorder interfering with ability to use the app Incarcerated Pregnant

Sites / Locations

  • UT Health San AntonioRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

KIOS Informational App evaluation

Arm Description

Study participants will use the app at least three times per week. The app will contain a user interface that includes a login page, true/false questions for the user to answer, verified public domain educational information about drug and alcohol use, Likert-type questions regarding the information presented, and a closing "Thank You" screen.

Outcomes

Primary Outcome Measures

Usability Score
The Systems Usability Scale-Modified is a non-health outcome, single-factor, 10-item self-report scale commonly used to evaluate participants' subjective experience using software. Systems Usability Scale yields a single number representing a composite measure of the overall usability of the system being studied. Systems Usability Scale scores have a range of 0 to 100, with higher scores representing a better outcome. Systems in early development may expect to have a rating of 30, while more mature systems should rate between 60 - 80.

Secondary Outcome Measures

User Satisfaction
A user satisfaction survey will be administered to evaluate the study participants' overall satisfaction with the app. This is a non-health outcome designed to better understand the user's perception of the app. The survey will consist of 20 statements that users will rate on a 1-7 Likert type scale (1=Disagree, 7= Agree). Satisfaction scores will be averaged and converted to percentages with higher percentages representing better user satisfaction with the app.

Full Information

First Posted
April 13, 2023
Last Updated
July 11, 2023
Sponsor
Biomedical Development Corporation
Collaborators
The University of Texas Health Science Center at San Antonio, National Institute on Drug Abuse (NIDA)
search

1. Study Identification

Unique Protocol Identification Number
NCT05859035
Brief Title
Informational App Development for mHealth for Patient Self-Management of Opioid Use Disorder
Acronym
KIOS-I
Official Title
Informational App Development for mHealth for Patient Self-Management of Opioid Use Disorder
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 29, 2023 (Actual)
Primary Completion Date
August 18, 2023 (Anticipated)
Study Completion Date
September 29, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Biomedical Development Corporation
Collaborators
The University of Texas Health Science Center at San Antonio, National Institute on Drug Abuse (NIDA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will evaluate the feasibility of an app that provides drug information to people in recovery from opioid use disorder. This study is designed to test the prototype app, not to determine health outcomes. The study will confirm the design and operating specifications prior to being evaluated in a larger clinical trial.
Detailed Description
The overall study is designed in two steps: 1) a one-week proof-of-concept study; and 2) a one-month pilot study. Step 1: A one-week proof-of-concept study will be performed in a small population (n=5) of individuals in opioid use disorder recovery as an indicator of the app's suitability. Study participants will use the sham app for one week and will then complete a usability and user satisfaction survey. If the app is found to be exhibit acceptable usability and satisfaction, a one month study will be completed in a larger sample (see Step 2, below). If not, modifications to the app will be made and the one-week study will be repeated in a new group of participants. Step 2: After completion of the proof-of-concept study, 20 new participants will be enrolled in a 4-week trial. Study participants will complete baseline assessments and then be asked to use the app at least three times per week, for four weeks. At the end of four weeks, participants will complete usability and user satisfaction surveys.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Opioid-Related Disorders

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
25 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
KIOS Informational App evaluation
Arm Type
Experimental
Arm Description
Study participants will use the app at least three times per week. The app will contain a user interface that includes a login page, true/false questions for the user to answer, verified public domain educational information about drug and alcohol use, Likert-type questions regarding the information presented, and a closing "Thank You" screen.
Intervention Type
Device
Intervention Name(s)
KIOS Informational App
Other Intervention Name(s)
KIOS-I
Intervention Description
The KIOS informational app will contain a user interface that includes a login page, true/false questions for the user to answer, verified public domain educational information about drug and alcohol use, Likert-type questions regarding the information presented, and a closing "Thank You" screen.
Primary Outcome Measure Information:
Title
Usability Score
Description
The Systems Usability Scale-Modified is a non-health outcome, single-factor, 10-item self-report scale commonly used to evaluate participants' subjective experience using software. Systems Usability Scale yields a single number representing a composite measure of the overall usability of the system being studied. Systems Usability Scale scores have a range of 0 to 100, with higher scores representing a better outcome. Systems in early development may expect to have a rating of 30, while more mature systems should rate between 60 - 80.
Time Frame
The Systems Usability Scale will be administered at the end of one-week for participants enrolled in Step 1 of the study and at the end of four-weeks for participants enrolled in Step 2.
Secondary Outcome Measure Information:
Title
User Satisfaction
Description
A user satisfaction survey will be administered to evaluate the study participants' overall satisfaction with the app. This is a non-health outcome designed to better understand the user's perception of the app. The survey will consist of 20 statements that users will rate on a 1-7 Likert type scale (1=Disagree, 7= Agree). Satisfaction scores will be averaged and converted to percentages with higher percentages representing better user satisfaction with the app.
Time Frame
A user satisfaction survey will be administered at the end of one-week for participants enrolled in Step 1 of the study and at the end of four-weeks for participants enrolled in Step 2.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male or female outpatients 18 years of age or older Currently enrolled in an opioid treatment program and receiving medication assisted treatment for opioid use disorder Currently stable in opioid use disorder outpatient treatment for 4 weeks or longer Ability to access the app via smart phone, or tablet. Exclusion Criteria: Unwilling or unable to comply with study requirements Have a psychiatric or medical disorder interfering with ability to use the app Incarcerated Pregnant
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jennifer Potter, Ph.D.
Phone
(210) 562-5418
Email
jspotter@uthscsa.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Meenakshi Rani, Ph.D.
Phone
210-358-0478
Email
rani@uthscsa.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jennifer Potter, Ph.D.
Organizational Affiliation
UT Health San Antonio
Official's Role
Principal Investigator
Facility Information:
Facility Name
UT Health San Antonio
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jennifer Potter, Ph.D.

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Informational App Development for mHealth for Patient Self-Management of Opioid Use Disorder

We'll reach out to this number within 24 hrs